Detail page

Knowledge Web

Person

Ulrike Protzer-Knolle (1962-)

Ärztin

Name	Ulrike Protzer-Knolle
Time	1962- (Date of birth and death)
Place	Deutschland
Gender	weiblich
Academic degree	Prof. Dr. med.
Profession	Ärztin (characteristic profession) Virologin
Variant	Ulrike Protzer- Knolle Ulrike Protzer (früherer Name) Ulrike Potzer (falsche Namensform)
Related	Technische Universität München. Institut für Virologie
Further information	Promotion 1990, Habilitation 2000
Record type	Person
GND-Identifier	112551920
Record ID	112551920
Involved in show all Multi-proteomic profiling of the varicella-zoster virus–host interface reveals host susceptibilities to severe infection Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning A novel HLA-DR13-restricted T cell epitope of the hepatitis B virus core protein spanning two overlapping binding registers SARS‐CoV‐2 productively infects human hepatocytes and induces cell death The association of immune kinetics and biomarkers with COVID-19 severity Adenoviral fiber-knob based vaccination elicits efficient neutralizing antibodies and T cell responses against adenovirus infection Multi-omics characterization of the monkeypox virus infection Analytical and clinical evaluation of a novel real-time PCR-based detection kit for Mpox virus A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis Viral genome sequencing to decipher in-hospital SARS-CoV-2 transmission events Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection Bedeutung des HLA-B*27-Allels für den Ausgang einer Hepatitis-Delta-Virus-Infektion Deciphering the Factors Involved in Unresponsiveness to Therapeutic Vaccination Against Chronic Hepatitis B Development of mRNA and deficient Sendai Virus vector vaccine against Human Norovirus Development of RNAi-based antiviral therapeutic strategies Dissecting the roles of HBV surface antigen locally expressed in the liver and secreted antigen in serum in mediating HBV immune tolerance Evaluation of strategies to increase safety of adoptive T-cell therapy against chronic hepatitis B Generation and functional analysis of spacer-modified HBV-specific chimeric antigen receptors that harboring a Fab fragment as the binding domain Generation of multicistronic DNA- and mRNA-based therapeutic vaccines against chronic hepatitis B virus infection Generation of recombinant MVA encoding HBV core and CD70 and evaluation of the co-stimulatory effect of CD70 in protein-prime/MVA boost vaccination in mice Immunometabolism and viral pathogenesis in hepatitis B virus infection Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages Applications of HBVenv-specific antibodies as research and therapeutic tools Etablierung und Evaluierung innovativer Stimulatorantigene zur Charakterisierung des zellulären Immunstatus von Patienten mit EBV-assoziierter Infektiöser Mononukleose Inhibition of SARS-CoV-2 infection by vaccine-induced antibodies and small-interfering RNAs SUMO modification of hepatitis B virus core mediates nuclear entry, promyelocytic leukemia nuclear body association, and efficient formation of covalently closed circular DNA Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook Correction to: Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism Antivirale Medikamente : Potente Wirkstoffe, Hoffnungsträger bei COVID‑19 und therapeutische Grenzen Analysing the role of human endogenous retrovirus, HERV-K(HML-2), on cortical neuron differentiation CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients Coronavirus-Pandemie: Die Feiertage und den Jahreswechsel für einen harten Lockdown nutzen : 7. Ad-hoc-Stellungnahme zr Coronavirus-Pandemie - 08.Dezember 2020 Estimation of the global distribution of hepatitis B virus genotypes and clinically relevant variants Generation and characterization of MHC class II-restricted T-cell receptors for T-cell therapy of chronic hepatitis B Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19 Gut microbial disruption in critically ill patients with COVID-19-associated pulmonary Aspergillosis Identifizierung und Charakterisierung von HBV-spezifischen T-Zell-Rezeptoren für die adoptive T-Zell-Therapie der Hepatitis B Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles Immunkontrolle der Hepatitis-Delta-Virus-Infektion in vitro und in vivo Investigation of species specificity of Na+ taurocholate cotransporting polypeptide for HBV infection and the evaluation of novel HBV entry inhibitors RNAi-mediated suppression of PD-L1 to restore Hepatitis B Virus-specific immunity and enhance the efficacy of therapeutic vaccination Untersuchung der Effekte von Core Protein Allosteric Modulators auf intrazelluläre Lokalisation und Modulation der Immunogenität des Hepatitis B Virus Core Proteins. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA) Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing Interferon‐induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20 SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11) Altered HBV-specific T-cell immunity in HBV/HIV co-infection and chronic hepatitis B Anti-HBs conjugated superparamagnetic iron oxide nanoparticles (SPION) to visualize and target HBV infection in vitro and in vivo Development of a thermostable, therapeutic vaccine against chronic hepatitis B Expression of human endogenous retrovirus type K HML2 in hepatitis C patients treated with direct acting antiviral therapy Generation and characterization of novel human monoclonal antibodies directed against the hepatitis B virus

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Ulrike Protzer-Knolle (1962-)

Multi-proteomic profiling of the varicella-zoster virus–host interface reveals host susceptibilities to severe infection

Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning

A novel HLA-DR13-restricted T cell epitope of the hepatitis B virus core protein spanning two overlapping binding registers

SARS‐CoV‐2 productively infects human hepatocytes and induces cell death

The association of immune kinetics and biomarkers with COVID-19 severity

Adenoviral fiber-knob based vaccination elicits efficient neutralizing antibodies and T cell responses against adenovirus infection

Multi-omics characterization of the monkeypox virus infection

Analytical and clinical evaluation of a novel real-time PCR-based detection kit for Mpox virus

A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection

Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis

Viral genome sequencing to decipher in-hospital SARS-CoV-2 transmission events

Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection

Bedeutung des HLA-B*27-Allels für den Ausgang einer Hepatitis-Delta-Virus-Infektion

Deciphering the Factors Involved in Unresponsiveness to Therapeutic Vaccination Against Chronic Hepatitis B

Development of mRNA and deficient Sendai Virus vector vaccine against Human Norovirus

Development of RNAi-based antiviral therapeutic strategies

Dissecting the roles of HBV surface antigen locally expressed in the liver and secreted antigen in serum in mediating HBV immune tolerance

Evaluation of strategies to increase safety of adoptive T-cell therapy against chronic hepatitis B

Generation and functional analysis of spacer-modified HBV-specific chimeric antigen receptors that harboring a Fab fragment as the binding domain

Generation of multicistronic DNA- and mRNA-based therapeutic vaccines against chronic hepatitis B virus infection

Generation of recombinant MVA encoding HBV core and CD70 and evaluation of the co-stimulatory effect of CD70 in protein-prime/MVA boost vaccination in mice

Immunometabolism and viral pathogenesis in hepatitis B virus infection

Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses

The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice

Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages

Applications of HBVenv-specific antibodies as research and therapeutic tools

Etablierung und Evaluierung innovativer Stimulatorantigene zur Charakterisierung des zellulären Immunstatus von Patienten mit EBV-assoziierter Infektiöser Mononukleose

Inhibition of SARS-CoV-2 infection by vaccine-induced antibodies and small-interfering RNAs

SUMO modification of hepatitis B virus core mediates nuclear entry, promyelocytic leukemia nuclear body association, and efficient formation of covalently closed circular DNA

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

Correction to: Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages

Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism

Antivirale Medikamente : Potente Wirkstoffe, Hoffnungsträger bei COVID‑19 und therapeutische Grenzen

Analysing the role of human endogenous retrovirus, HERV-K(HML-2), on cortical neuron differentiation

CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

Coronavirus-Pandemie: Die Feiertage und den Jahreswechsel für einen harten Lockdown nutzen : 7. Ad-hoc-Stellungnahme zr Coronavirus-Pandemie - 08.Dezember 2020

Estimation of the global distribution of hepatitis B virus genotypes and clinically relevant variants

Generation and characterization of MHC class II-restricted T-cell receptors for T-cell therapy of chronic hepatitis B

Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19

Gut microbial disruption in critically ill patients with COVID-19-associated pulmonary Aspergillosis

Identifizierung und Charakterisierung von HBV-spezifischen T-Zell-Rezeptoren für die adoptive T-Zell-Therapie der Hepatitis B

Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles

Immunkontrolle der Hepatitis-Delta-Virus-Infektion in vitro und in vivo

Investigation of species specificity of Na+ taurocholate cotransporting polypeptide for HBV infection and the evaluation of novel HBV entry inhibitors

RNAi-mediated suppression of PD-L1 to restore Hepatitis B Virus-specific immunity and enhance the efficacy of therapeutic vaccination

Untersuchung der Effekte von Core Protein Allosteric Modulators auf intrazelluläre Lokalisation und Modulation der Immunogenität des Hepatitis B Virus Core Proteins.

Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern

Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA)

Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing

Interferon‐induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20

SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic

Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting

S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)

Altered HBV-specific T-cell immunity in HBV/HIV co-infection and chronic hepatitis B

Anti-HBs conjugated superparamagnetic iron oxide nanoparticles (SPION) to visualize and target HBV infection in vitro and in vivo

Development of a thermostable, therapeutic vaccine against chronic hepatitis B

Expression of human endogenous retrovirus type K HML2 in hepatitis C patients treated with direct acting antiviral therapy

Generation and characterization of novel human monoclonal antibodies directed against the hepatitis B virus